Pylopass (L. reuteri DSM 17648) - 30 Capsules | Daily

Pylopass™ contains one Limosilactobacillus reuteri DSM17648, a single bacterial strain identified by screening more than 700 Lactobacillus strains for one specific characteristic: the ability to bind to Helicobacter pylori cells and reduce the bacterial load.

Mechanism: Forms clumps around H.pylori cells, which coaggregate (attach) around the bacteria and slowly remove them from the stomach and into the stool, ready to be passed out.

Postbiotic: Can be used alongside antibiotics. The strain is inactivated using a specialist spray-drying process and works autonomously in the stomach.

Highly selective: In our trials, DSM17648 bound several different H. pylori strains, giving it versatility across the world.

Stomach pH: Pylopass was unaffected by high or low stomach acid between pH 2 and 8. This makes it perfect for low-acid and high-acid environments. This allows it to be used alongside PPIs.

No refrigeration needed: The cells are inactive, so it doesn't require refrigeration, meaning it's stable at room temperature and in warmer environments that don't affect its stability.

200mg per serving: One capsule delivers 20 billion cells, the daily amount used in all our clinical trials.